January 10, 2026

Aston Sci. Inc., a clinical-stage biopharmaceutical company focused on advancing next-generation therapeutic cancer vaccines, has announced the adoption of

Researchers at Tokyo Metropolitan University have developed an artificial intelligence–based system that can automatically detect and count sister chromatid